- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Adenocarcinoma in Situ in Singapore
Total 830 results
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedPhase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLCRecurrent Non Small Cell Lung CancerUnited States, Singapore
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
ImunonCompletedHepatocellular CarcinomaKorea, Republic of, China, Hong Kong, Singapore, Thailand, Malaysia, United States, Canada, Taiwan, Spain, Philippines, Germany, Italy, Vietnam
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States, China, Hungary, Taiwan, Belgium, Germany, Spain, Italy, Czechia, France, Japan, Switzerland, Australia, Israel, Korea, Republic of, Canada, Russian Federation, Slovakia, United Kingdom, Turkey, Sweden, Greece, Finland, ... and more
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
-
Prestige Biopharma LimitedRecruitingPancreatic CancerSpain, Singapore, United States
-
Sabine RhodeRuhr University of BochumUnknownGastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural CancerSingapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
-
Novartis PharmaceuticalsActive, not recruitingCarcinoma, Renal CellSpain, Singapore, Czechia, Italy, Japan, France, United States
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungJapan, Korea, Republic of, Singapore
-
TularikTerminatedHepatocellular CarcinomaUnited States, Russian Federation, United Kingdom, Singapore, Thailand, Ukraine, Brazil, China, Poland, Puerto Rico, South Africa
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
Chinese University of Hong KongChangi General Hospital; Kosin University Gospel Hospital; Shizuoka Cancer Center and other collaboratorsCompletedEarly Gastric Cancer | Gastric NeoplasmJapan, Singapore, Korea, Republic of, Hong Kong
-
Azienda Ospedaliero-Universitaria CareggiSocietà Italiana di Urologia (SIU); Italian Group for Advanced Laparo-Endoscopic...RecruitingKidney CancerItaly, United States, Spain, United Kingdom, Belgium, Austria, Brazil, Greece, Japan, Netherlands, Poland, Russian Federation, Singapore
-
Bristol-Myers SquibbRecruitingCarcinoma, HepatocellularUnited States, Taiwan, Spain, France, Korea, Republic of, Germany, Puerto Rico, China, Japan, Canada, Hong Kong, Australia, Poland, Singapore, Italy
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
Bristol-Myers SquibbActive, not recruitingHepatocellular Carcinoma | Hepatoma | Liver Cell Carcinoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultChile, Brazil, Argentina, China, Czechia, France, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Singapore, Spain, Taiwan, Turkey
-
BayerCompletedCarcinoma, HepatocellularBelgium, China, Hong Kong, Switzerland, Japan, France, Spain, Germany, United States, Austria, Czechia, United Kingdom, Korea, Republic of, Thailand, New Zealand, Hungary, Israel, Italy, Taiwan, Singapore, Turkey
-
The Cleveland ClinicCompletedBreast NeoplasmsUnited States, Austria, Singapore, China, Ireland, Germany
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
BerGenBio ASATerminatedOvarian NeoplasmsKorea, Republic of, Singapore, United Kingdom, Norway
-
BayerCompletedCarcinoma, HepatocellularBelgium, France, Spain, China, Canada, Singapore, United States, Germany, Australia, Austria, Korea, Republic of, Italy, Taiwan
-
H3 Biomedicine Inc.Eisai Inc.CompletedLiver Neoplasms | Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Liver Cancer | Hepatic Cancer | Hepatic CarcinomaFrance, United States, Belgium, Spain, Taiwan, Korea, Republic of, Russian Federation, Canada, Italy, Singapore, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular CarcinomaUnited States, Singapore, Spain, United Kingdom, Germany, Italy, Canada, France, Hong Kong, Japan, Korea, Republic of, Puerto Rico, Taiwan
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Korea, Republic of, United Kingdom, Canada, China, Hong Kong, Taiwan, Australia, Italy, Spain, Czechia, Japan, Singapore, France, Germany, Poland, Russian Federation
-
AmgenZai Lab (China only)RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaCanada, Japan, United States, Korea, Republic of, China, Italy, Australia, Sweden, Spain, Taiwan, France, Belgium, Denmark, Thailand, Turkey, Czechia, Bulgaria, Brazil, Norway, Mexico, Poland, Estonia, Israel, Greece, Romania, Chile, Peru, Po... and more
-
National Cancer Center, JapanRecruitingCervical Cancer | Nasopharyngeal Carcinoma | Ovarian Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Ovarian Clear Cell CarcinomaJapan, Korea, Republic of, Malaysia, Thailand, Philippines, Singapore, Taiwan, Vietnam
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedUnresectable Hepatocellular CarcinomaKorea, Republic of, United States, Spain, France, United Kingdom, Canada, Germany, Singapore, Netherlands, Belgium, Italy
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Israel, Italy, Spain, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Japan, Taiwan, China, Belgium, Poland, Thailand, Czechia, Singapore, Hungary, Argentina, Brazil, Romania, Portuga... and more
-
Novartis PharmaceuticalsTerminatedEarly Breast CancerSpain, Singapore, United States
-
BayerCompletedCarcinoma, HepatocellularBelgium, France, Spain, Hong Kong, United States, Canada, Germany, Greece, New Zealand, Russian Federation, Australia, Taiwan, Austria, United Kingdom, China, Israel, Korea, Republic of, Bulgaria, Brazil, Poland, Italy, Colombia, South... and more
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedGastric CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
ExelixisCompletedHepatocellular CarcinomaBelgium, Hong Kong, Korea, Republic of, Canada, France, Taiwan, United States, Germany, Spain, United Kingdom, Singapore, Australia, Italy, Netherlands, Poland, Turkey, Ireland, New Zealand, Romania
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
BayerCompletedCarcinoma, HepatocellularFrance, Spain, China, Switzerland, United States, Singapore, Germany, Russian Federation, Taiwan, Austria, Czechia, United Kingdom, Korea, Republic of, Australia, Hungary, Italy, Netherlands, Japan, Belgium, Brazil, Argentina
-
National University Hospital, SingaporeNational Taiwan University Hospital; Chinese University of Hong Kong; Singapore... and other collaboratorsActive, not recruitingStomach NeoplasmTaiwan, United States, Singapore, Hong Kong, Japan, Korea, Republic of
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingCarcinoma, HepatocellularUnited States, Canada, Korea, Republic of, Taiwan, Brazil, Belgium, China, Puerto Rico, Japan, New Zealand, Mexico, Spain, Germany, Poland, Thailand, Singapore, Hong Kong, France, Turkey, Italy, United Kingdom, South Africa, Côte D'Ivoire
-
PfizerTerminatedCarcinoma, HepatocellularUnited States, Belgium, Spain, Canada, Italy, Korea, Republic of, Poland, Turkey, Germany, Singapore, Taiwan, China, France, Hong Kong, South Africa, Australia, Japan, Sweden, Malaysia, Philippines, Thailand, Russian Federation, United...
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
R-PharmCompletedStomach NeoplasmsKorea, Republic of, Taiwan, Japan, Singapore, Hong Kong
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHepatocellular CarcinomaUnited States, Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Boehringer IngelheimTerminatedHead and Neck NeoplasmsSingapore, China, Korea, Republic of, Taiwan
-
The Hospital for Sick ChildrenTerry Fox FoundationActive, not recruitingRetinoblastomaCanada, Chile, India, Singapore
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, France, Taiwan, Thailand, Vietnam, Italy, Korea, Republic of, Brazil, India, Japan, Mexico, Russian Federation, China, Hong Kong, Australia, Spain, Singapore
-
Hoffmann-La RocheCompletedRenal Cell CancerItaly, Spain, Germany, Switzerland, Russian Federation, Czech Republic, France, United Kingdom, Belgium, Singapore, Hungary, Poland, Israel, Taiwan, Australia, Finland, Netherlands, Norway
-
Zeria PharmaceuticalCompletedCervical CancerJapan, Korea, Republic of, Malaysia, Singapore, Taiwan, Thailand, Vietnam
-
Bristol-Myers SquibbActive, not recruitingHepatocellular CarcinomaGermany, Romania, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland and more